MoneyPati

Learn Stock Market Investing and Trading for Free



Solara Active Pharma Stock Analysis

Solara Active Pharma Sciences Limited Detail

Solara Active Pharma Sciences Limited is in portfolio of Satpal Khattar. He is one of the top investors in India. The company belongs to Pharmaceutical sector. 

As per the Company website it is in business of API manufacture for Pharmaceuticals. Select API business of Strides Shasun were demerged to integrate with Human API business of Sequent which gave birth to Solara Active Pharma Sciences.

The Company has four manufacturing sites and two R&D sites. The manufacturing sites are located in Puducherry, Cuddalore, Mangalore, Ambernath and Mysore. The Research and Development sites are located in Bangalore and Chennai.

It has divided business focus area into three categories

Some of the key products offered by the Company are listed below

I have shared long term price performance chart of the Company below.As per Dow theory of technical analysis price performance over a period of time reflects Company state.

Solara Active Pharma Sciences Limited Stock Performance

The stock is new listing on stock exchanges. It got listed in year 2018 at price of 250 INR. This was not good time to get listed as market were indecisive. But after some hiccups it performed well and has given positive returns to investors as of now.

It has rose steadily over the years as you can see in above chart. This incremental movement upwards is what I like about any stock. It shows gradual shifting of results towards positive side.

Note this was not a good time for Pharma stocks as well. Majority of Pharma companies were not performing during this time frame. So above performance is decent.

Solara Active Pharma Sciences Limited My Opinion

Sequent Scientific Limited is an Pharma Company. It was born out of Strides Pharma and Sequent Scientific.

You can view it as Human Health API business of Sequent Sciences with some API and knowledge from Strides side as well. Note the ace investors is invested in all three entities. This makes the case very interesting. He seems to be very bullish on these three Pharma companies.

I have already invested into Pharma space and not willing to increase exposure in it. The Company is rip off of Sequent Sciences and Strides. So I would like to observe it more before making any judgement on tracking it. As of now there are better alternatives available in market.

In case you are interested then you can track the company by adding it to your stock watch list. That way you can keep close eye on the Company.